The estimated Net Worth of Alfred Lewis Goldberg is at least $15.1 Milion dollars as of 10 August 2011. Alfred Goldberg owns over 21,000 units of Repligen stock worth over $15,057,000 and over the last 16 years Alfred sold RGEN stock worth over $0.
Alfred has made over 1 trades of the Repligen stock since 2011, according to the Form 4 filled with the SEC. Most recently Alfred bought 21,000 units of RGEN stock worth $72,030 on 10 August 2011.
The largest trade Alfred's ever made was buying 21,000 units of Repligen stock on 10 August 2011 worth over $72,030. On average, Alfred trades about 2,100 units every 0 days since 2008. As of 10 August 2011 Alfred still owns at least 105,000 units of Repligen stock.
You can see the complete history of Alfred Goldberg stock trades at the bottom of the page.
Alfred's mailing address filed with the SEC is 41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453.
Over the last 22 years, insiders at Repligen have traded over $118,224,292 worth of Repligen stock and bought 160,440 units worth $1,459,521 . The most active insiders traders include Partners L P/Ilbiotechnolog..., Glenn P Muir a Walter C Herlihy. On average, Repligen executives and independent directors trade stock every 33 days with the average trade being worth of $3,015,702. The most recent stock trade was executed by Ralf Kuriyel on 2 August 2024, trading 7,148 units of RGEN stock currently worth $1,139,034.
repligen corporation is a life sciences company focused on the development, production and commercialization of products used in the process of manufacturing biological drugs. our bioprocessing products are sold to major life sciences and biopharmaceutical companies worldwide. we are a leading manufacturer of protein a, a critical reagent used to manufacture monoclonal antibody-based therapeutics. we also supply several growth factor products used to increase cell culture productivity in biomanufacturing. in the burgeoning area of disposable biomanufacturing technologies, we have developed and market a series of opus™ (open platform user specified) single-use chromatography columns used in the biologics purification process. repligen’s corporate headquarters are located in waltham, ma, usa; we have an additional manufacturing facility in lund, sweden.
Repligen executives and other stock owners filed with the SEC include: